Diagnostic validation study reveals rapid electrochemical susceptibility testing yields 87.9% categorical agreement in clinical urine samples within 6.0 hours, suggesting faster targeted treatment.
Introduction Phenotypic antibiotic susceptibility testing (AST) is essential, but conventional culture-based methods require 48–72 h, delaying targeted treatment. Here we report a first small study of a direct electrochemical AST system on clinical urine samples. The study aimed to validate the technology and support further research. Methods 18 urine and 2 control samples were tested with 3 antibiotics above and below EUCAST breakpoints, resulting in 474 antibiotic-sample combinations grouped as 158 triplets. Results Using routine clinical diagnostics as reference method, categorical agreement, sensitivity, and specificity were 87.9% (95% CI, 83.7–91.1%), 0.95 (95% CI, 0.8952–0.9769) and 0.831 (95% CI, 0.7684–0.8786), respectively. The average time to result was 6.0 ± 3.3 h. Its non-species-specific electrochemical principle theoretically allows it to be applied to various sample types and organisms. Discussion These results demonstrate that the electrochemical AST platform provides accurate results on the same day directly from patient samples, likely eliminating the need for mandatory pre-culturing.
No takes yet. Share an insight, caveat, or question.
Riester et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: